FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, namely to the Lactobacillus crispatus KBL693 strain and to its application. Lactobacillus crispatus KBL693 strain (identification number KCTC 13519BP) in accordance with the present invention weakens allergic cellular reactions, significantly improves the symptoms of atopic dermatitis and has anti-inflammatory and antifungal effects. Thus, this single strain by itself can achieve all the goals of mitigating atopic dermatitis and other allergic diseases and improving the condition with inflammatory diseases and autoimmune diseases and thereby successfully find use as a probiotic substance.
EFFECT: this strain, based on its antifungal activity, can be successfully used as a means for external skin treatment against various skin diseases caused by fungi, as well as in a cosmetic composition and functional strip to soften skin sensitivity.
25 cl, 16 dwg, 4 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN LACTOBACILLUS GASSERI KBL697 AND ITS USE | 2019 |
|
RU2798872C2 |
| LACTOBACILLUS PARACASEI STRAIN AND ITS USE | 2019 |
|
RU2790297C2 |
| NEW LACTIC ACID BACTERIA AND APPLICATION THEREOF | 2018 |
|
RU2752157C2 |
| NEW LACTOBACILLUS PLANTARUM STRAIN, COMPOSITIONS CONTAINING IT, AND RELATED METHOD AND ITS USE | 2018 |
|
RU2790442C2 |
| COMPOSITION, CONTAINING PROBIOTIC BACTERIA FOR USE IN TREATING IMMUNE DISORDERS | 2011 |
|
RU2605293C2 |
| COMPOSITION COMPRISING PROBIOTIC BACTERIA FOR USE IN TREATING IMMUNE DISORDERS | 2011 |
|
RU2712751C2 |
| PROBIOTIC STRAIN OF Bifidobacterium longum, COMPOSITION CONTAINING SUCH STRAIN AND USE THEREOF | 2008 |
|
RU2473681C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ATTENUATED Streptococcus pneumoniae STRAINS, AND ITS APPLICATION | 2018 |
|
RU2772131C2 |
| MUCOSAL INDUCTION OF ANTIGEN TOLERANCE | 2006 |
|
RU2420569C2 |
| PROBIOTIC STRAIN Bifidobacterium longum, PROBIOTIC COMPOSITION AND USE OF STRAIN Bifidobacterium longum | 2008 |
|
RU2466185C2 |
